MedTrace Logo

Diabetic Cardiomyopathy and Heart Failure

NCT05571865 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2025-01-31

No results posted yet for this study

Summary

This study will demonstrate the beneficial effects of ketone bodies in type 1 diabetes (T1D) patients and will have significant translational applications to prevent serious metabolic conditions such as T1D induced diabetic cardiomyopathy (DCM).

Conditions

Interventions

DIETARY_SUPPLEMENT

Probiotic

Oral administration of a probiotic

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • University of Louisville

    lead OTHER

Principal Investigators

  • Mahavir Singh, DVM, MS, PhD · University of Louisville School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-31
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05571865 on ClinicalTrials.gov